Invenio Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$715K Sell
5,564
-68
-1% -$7.96K 0.26% 46
2026
Q1
$677K Sell
5,632
-1,278
-18% -$148K 0.27% 43
2025
Q4
$727K Sell
6,910
-318
-4% -$29.9K 0.27% 44
2025
Q3
$607K Buy
7,228
+33
+0.5% +$2.72K 0.22% 54
2025
Q2
$570K Buy
7,195
+2,789
+63% +$222K 0.23% 53
2025
Q1
$395K Buy
4,406
+874
+25% +$81.6K 0.17% 61
2024
Q4
$351K Sell
3,532
-1,148
-25% -$118K 0.15% 67
2024
Q3
$531K Sell
4,680
-124
-3% -$14.7K 0.23% 51
2024
Q2
$595K Sell
4,804
-60
-1% -$7.73K 0.29% 46
2024
Q1
$642K Sell
4,864
-304
-6% -$37.5K 0.35% 43
2023
Q4
$563K Buy
5,168
+838
+19% +$87K 0.41% 45
2023
Q3
$446K Buy
4,330
+372
+9% +$40.1K 0.41% 49
2023
Q2
$457K Buy
+3,958
New +$449K 0.52% 39

Other funds holding MRK

Invenio Wealth Partners's MRK Position: Q2 2026 in Review

Invenio Wealth Partners reduced its Merck (MRK) stake by 1.2% in Q2 2026, selling an estimated $7.96K and leaving 5,564 shares worth $715K. The position accounts for 0.26% of the portfolio, ranked #46.

Invenio Wealth Partners first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. The position peaked at $727K in Q4 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Invenio Wealth Partners held 5,564 shares of Merck worth $715K as of Q2 2026.
  • Invenio Wealth Partners sold 68 Merck shares in Q2 2026, an estimated $7.96K.
  • Merck made up 0.26% of Invenio Wealth Partners's portfolio in Q2 2026, its #46 holding.
  • Invenio Wealth Partners first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • Invenio Wealth Partners's Merck position peaked at $727K in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Invenio Wealth Partners's 13F filing for Q2 2026, filed 30 Jul 2026.